FridayJan 06, 2023 9:45 am

MetAlert, Inc. (MLRT) – Offering More Than Location-Sensitive Health Monitoring Devices

The CDC estimates that by 2060, over 14 million Americans may be diagnosed with Alzheimer’s, up from the current 6.5 million In a surprising study, presented at the 2022 Alzheimer’s Association International Conference, it was noted that this rise could be largely attributed to people’s intake of ultra-processed foods, which was linked to a higher risk of dementia Of the 10,000 participants who took part in the study, it was noted that those who ate the most ultra-processed foods had a 28% faster rate of global cognitive decline, and a 25% faster rate of executive function decline compared to those…

Continue Reading

ThursdayJan 05, 2023 12:25 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Issues Shareholder Update

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, today issued its year-end shareholder letter. In the update, the company’s CEO and Founder Patrick Bertagna shared insight on the company’s restructuring, branding and efforts to attract new investors and larger customers to execute its growth strategy, as well as the milestones that will shape MetAlert’s future. “We are now taking dramatic steps to align the public-facing (stock) part of the company with the operations and vision of the company. Although the short-term performance of the stock has not been what we…

Continue Reading

WednesdayJan 04, 2023 9:00 am

MetAlert, Inc. (MLRT) Recognizes Link Between Cognition in Aging Population and Use of Hearing Aids

MetAlert has, since its inception, sought to offer quality-of-life improvements to patients and caregivers dealing with Alzheimer’s, dementia, and autism (“ADA”) This focus has led to the company offering products and services within the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring Also important is MetAlert’s offering of hearing aids, ranging from its flagship Hear IQ 4 rechargeable, app-controlled hearing aid, the NRBz noise-reducing buds, HearingVite, and the Ear-Ring Relief formula MetAlert understands the correlation between cognitive decline and hearing loss, with persons with hearing loss who wore devices performing better on cognitive scores…

Continue Reading

WednesdayDec 28, 2022 11:02 am

QualityStocksNewsBreaks – MetAlert Inc.’s (MLRT) RoomMate(TM) Delivers Efficiency, Privacy for Alzheimer’s, Dementia and ADA Patients

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products, recently signed a letter of intent (“LOI”) with Sensio Group, a Norway-based provider of welfare technology and home automation solutions, for the marketing and distribution of RoomMate(TM). “RoomMate, one of MetAlert’s flagship products, is a wall-mounted alert system that delivers both efficiency and privacy. It detects and alerts caregivers about patient behavior that could lead to falls and injuries, using 3D infrared and wall-mounted sensors that eliminate the need for any other physical installations or wearables. Unlike more mainstream patient monitoring systems, RoomMate does not use…

Continue Reading

TuesdayDec 27, 2022 10:30 am

Advisory Firm Appointment Underscores MetAlert, Inc. (MLRT) Strategy Amid Growth Stage and New Patient Location-tracking Technology Rollout

Pioneering GPS-enabled location device developer MetAlert is building on two decades of experience with new products designed to broaden its suite of technology for remote patient monitoring (“RPM”) in an unobtrusive manner plus monitoring seniors for falls MetAlert recently announced that it has engaged the financial strategy advisory firm Joseph Gunnar & Co., LLC to help direct its decisions ranging from acquisitions to potential up listing on a national exchange The company’s products include its flagship patented shoe insole device enabled with GPS, Bluetooth, and Wi-Fi functionality for tracking seniors or people with autism prone to wandering and getting lost,…

Continue Reading

FridayDec 16, 2022 3:32 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Collaborates to Launch Game-Changing, Potentially Lifesaving GPS SmartSole in Canada

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products, is a solution leader for consumers and patients with needs for remote monitoring. “MetAlert has announced that Canadian distributor Red Dot Alerts has launched the new award-winning 4G GPS SmartSole – a wearable medical monitoring device integrated into the orthotic insole allowing for discreet tracking and remote monitoring for those with Alzheimer’s, dementia and autism. The launch is supported by a marketing and advertising campaign, including radio and magazine ads and mailers to medical clinics, hospitals, pharmacies, and senior residence facilities across Canada. The advertising campaign…

Continue Reading

FridayDec 16, 2022 11:15 am

MetAlert, Inc. (MLRT) Going into 2023 in a Much Healthier Position after Eliminating All Toxic Debt in Q4 2022 and Launching New Remote Patient Monitoring Medical Devices

Ludlow Research ups price target for MetAlert, leading developer of location-sensitive health monitoring devices and wearable technology products, anticipating target between $1 and $1.25 per share MetAlert announced the elimination of all its toxic convertible notes from its balance sheet, which now provides increased stability to its public float The company also shared improved guidance to its NFC operations while also announcing the launch of new medical devices geared toward the geriatric and autism healthcare markets Q4 2022 also saw the influx of new chips, which will significantly increase production of the company’s SmartSole units in early 2023, ramp up…

Continue Reading

FridayDec 09, 2022 11:25 am

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Featured in ‘Stocks to Watch’ by Markets Herald

MetAlert (OTC: MLRT) is a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring. The company was featured in a “Stocks to Watch” report published by Markets Herald, which offers current market trends and analysis across various sectors. “MetAlert (OTC: MLRT) took a significant step forward in the fourth quarter of 2022 by eliminating all toxic convertible notes from its balance sheet,” the publication reads. “This move, along with improved guidance to operations, provides investors with increased stability to the public float. In addition, MetAlert is launching new medical devices geared toward the geriatric and…

Continue Reading

FridayDec 09, 2022 9:00 am

MetAlert Inc. (MLRT) to Begin Marketing and Distribution of RoomMate(TM) in the U.S., Canada, and the U.K., following Partnership with Sensio Group

MetAlert recently announced the signing of an LOI with Sensio Group for the marketing and distribution of RoomMate, a 3D Infrared supervision product with a fall detection automated monitoring system The company has set out to solve problems unique to individuals afflicted with ADA by creating devices specific to their use cases, and RoomMate is one such product, promising effective remote patient monitoring while maintaining anonymity Through this partnership, MetAlert looks to penetrate the high CAGR projected patient monitoring devices market, valued at $47 billion in 2021 It also looks to leverage the partnership for future up-listing onto a major…

Continue Reading

WednesdayDec 07, 2022 2:42 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Featured in Research Report

Ludlow Research has announced that it updated its research opinion on MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring. The update is based on MetAlert’s elimination of toxic debt, as well as the launch of new medical device products for cognitive markets. “Toxic debt, or variable convertible notes, are a form of debt, which sometimes convert at deep discounts to market price, and are major contributors to shareholder dilution and price instability for small issuers. In recent months, MetAlert extinguished all of their toxic convertible notes from their balance sheet,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered